FEDERATED HERMES, INC. - ACADIA PHARMACEUTICALS INC ownership

ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 300 filers reported holding ACADIA PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 1.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ACADIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$2,286,502
+614.3%
109,717
+720.9%
0.01%
+500.0%
Q2 2023$320,116
+28739.3%
13,366
+22554.2%
0.00%
Q1 2023$1,110
-21.7%
59
-33.7%
0.00%
Q4 2022$1,417
-29.2%
89
-36.0%
0.00%
Q3 2022$2,000
-98.1%
139
-98.2%
0.00%
Q2 2022$107,000
-97.9%
7,586
-96.4%
0.00%
-100.0%
Q1 2022$5,169,000
-79.3%
213,426
-80.0%
0.01%
-73.9%
Q4 2021$24,948,000
+125.3%
1,068,904
+60.3%
0.05%
+119.0%
Q3 2021$11,075,000
-57.1%
666,752
-33.3%
0.02%
-58.0%
Q1 2021$25,800,000
+15924.8%
1,000,000
+29921.0%
0.05%
Q2 2020$161,000
-95.5%
3,331
-96.0%
0.00%
-100.0%
Q4 2019$3,598,000
-31.9%
84,108
-42.7%
0.01%
-38.5%
Q3 2019$5,282,000
+114.7%
146,767
+59.5%
0.01%
+116.7%
Q2 2019$2,460,000
+245900.0%
92,039
+460095.0%
0.01%
Q3 2018$1,000
-100.0%
20
-100.0%
0.00%
-100.0%
Q4 2017$2,110,000
-41.9%
70,088
-27.3%
0.01%
-40.0%
Q3 2017$3,631,000
-69.5%
96,399
-74.3%
0.01%
-70.6%
Q3 2016$11,924,000
-25.3%
374,860
-23.8%
0.03%
-27.7%
Q2 2016$15,963,000
+16.1%
491,7600.0%0.05%
+9.3%
Q1 2016$13,750,000
-21.6%
491,7600.0%0.04%
-21.8%
Q4 2015$17,531,000
-34.2%
491,760
-39.0%
0.06%
-36.0%
Q3 2015$26,646,000
+5.3%
805,760
+33.4%
0.09%
+13.2%
Q2 2015$25,296,000
+22.5%
604,000
-4.6%
0.08%
+20.6%
Q1 2015$20,643,000
+550.2%
633,400
+533.4%
0.06%
+530.0%
Q4 2014$3,175,000100,0000.01%
Other shareholders
ACADIA PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Baker Brothers Advisors 27,228,338$611,821,0005.19%
First Washington CORP 176,950$3,976,0002.06%
SECTORAL ASSET MANAGEMENT INC 783,424$17,604,0001.93%
HARVEY CAPITAL MANAGEMENT INC 219,042$4,921,0001.84%
Ghost Tree Capital, LLC 400,000$8,988,0001.82%
Opus Point Partners Management, LLC 36,733$825,0001.62%
Palo Alto Investors LP 1,650,780$37,093,0001.59%
EMORY UNIVERSITY 84,714$1,904,0001.36%
GARRISON BRADFORD & ASSOCIATES INC 69,000$1,550,0001.32%
HealthCor Management, L.P. 1,378,000$30,964,0001.05%
View complete list of ACADIA PHARMACEUTICALS INC shareholders